Drugs News and Research

RSS

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.

11 Nov 2013

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.

11 Nov 2013

First Edition: November 11, 2013

Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.

11 Nov 2013

FDA proposes rule to speed dissemination of new safety information about generic drugs

A proposed U.S. Food and Drug Administration rule would speed the dissemination of new safety information about generic drugs to health professionals and patients by allowing generic drug makers to use the same process as brand drug manufacturers to update safety information in the product labeling.

11 Nov 2013

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

BioInvent International AB today announces that it has been granted a US patent for its antibody and concomitant target discovery technology F.I.R.S.T.

11 Nov 2013

ChinaSoft inks agreement with CITIC 21CN on Pharmaceutical Information Sharing Program

ChinaSoft International Limited, announced that it has signed a strategic agreement with CITIC 21CN Company Limited on the Pharmaceutical Information Sharing Program.

11 Nov 2013

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.

11 Nov 2013

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Each week, KHN compiles a selection of recently released health policy studies and briefs.

11 Nov 2013

Research provides new understanding of the effects of race on heart disease

Thomas Jefferson University researchers have discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a new understanding of the effects of race on heart disease. The finding could one day help doctors provide more individualized treatment of heart disease and other blood-clot-related illnesses, according to research publishing online November 10th in Nature Medicine.

11 Nov 2013

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.

11 Nov 2013

Study: Infants attributed to sudden infant death syndrome may be due to brainstem abnormalities

Investigators at Boston Children's Hospital report that infants dying suddenly and unexpectedly, in both safe and unsafe sleep environments, have underlying brainstem abnormalities and are not all normal prior to death.

11 Nov 2013

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

11 Nov 2013

A*STAR scientists discover potential target to weed out progression of cancer

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.

10 Nov 2013

Genetic variations in African Americans with kidney disease contribute to rapid decline in kidney function

New research provides direct evidence that genetic variations in some African Americans with chronic kidney disease contribute to a more rapid decline in kidney function compared with white Americans.

10 Nov 2013

Tissue scarring may help develop new treatments for patients with damaged organs

Patients with damaged organs could be helped by new treatments after scientists have discovered how tissues scar.

10 Nov 2013

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Scientists are gaining a new level of understanding of multiple sclerosis that may lead to new treatments and approaches to controlling the chronic disease, according to new research released today at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

10 Nov 2013

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Aptiom receives FDA approval to treat seizures associated with epilepsy

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

10 Nov 2013

Adherence to suicide risk assessment urged for schizophrenia patients

Many patients with schizophrenia who attempt suicide after hospital discharge missed out on a pre-discharge suicide risk assessment, shows a study from Denmark. .

8 Nov 2013

Breast cancer drug appears to protect cells against UV radiation, inflammation

Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.

8 Nov 2013

Drugs News and Research

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

First Edition: November 11, 2013

FDA proposes rule to speed dissemination of new safety information about generic drugs

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

ChinaSoft inks agreement with CITIC 21CN on Pharmaceutical Information Sharing Program

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Research provides new understanding of the effects of race on heart disease

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

Study: Infants attributed to sudden infant death syndrome may be due to brainstem abnormalities

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

A*STAR scientists discover potential target to weed out progression of cancer

Genetic variations in African Americans with kidney disease contribute to rapid decline in kidney function

Tissue scarring may help develop new treatments for patients with damaged organs

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Aptiom receives FDA approval to treat seizures associated with epilepsy

Adherence to suicide risk assessment urged for schizophrenia patients

Breast cancer drug appears to protect cells against UV radiation, inflammation

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News